Stock COSM COSMOS HEALTH INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Cosmos Health Inc.

Equities

COSM

US2214133058

Delayed Nasdaq
Other stock markets
 08:24:05 27/06/2024 pm IST 		5-day change 1st Jan Change
0.635 USD -1.55% Intraday chart for Cosmos Health Inc. -11.68% -54.96%
18/06 Cosmos Health to Acquire Full Rights to Patent Targeting Central Nervous System Cancers MT
21/03 Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent
AQ
Cosmos Health to Acquire Full Rights to Patent Targeting Central Nervous System Cancers
MT
Cosmos Health Participated in Vitafoods Europe 2024, Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand
AQ
Cosmos Health : Change in Certifying Accountants - Form 8-K
PU
Cosmos Health : RELATED PARTY TRANSACTION POLICIES AND PROCEDURES - Form 8-K
PU
Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform
CI
Cosmos Health Inc. Receives Regulatory Approval to Sell Sky Premium Life Products in UAE Nutritional Supplements Market
CI
Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets, Expects to Increase FY 2024 Annual Revenue by over $5 Million
AQ
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
AQ
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
AQ
Cosmos Health Acquires Rights to Patent for Drug Targeting Central Nervous System Cancers
MT
Cosmos Health Files Patent Application for Obesity, Weight Management Product With European Patent Office
MT
Tranche Update on Cosmos Health Inc.'s Equity Buyback Plan announced on January 24, 2023.
CI
Cosmos Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Cosmos Health Insider Bought Shares Worth $158,806, According to a Recent SEC Filing
MT
Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform, Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders
AQ
Sector Update: Health Care Stocks Softer Late Afternoon
MT
Sector Update: Health Care Stocks Drop Wednesday Afternoon
MT
Cosmos Health Says it has Agreed to Buy Cloudscreen in a Cash-and-Stock Deal.
MT
Cosmos Health Inc. has entered into a purchase agreement to acquire Cloudscreen.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. COSM Stock
  4. News Cosmos Health Inc.